Roth Mkm lowered shares of Acer Therapeutics (NASDAQ:ACER – Free Report) from a buy rating to a neutral rating in a research note published on Friday, MarketBeat reports. Roth Mkm currently has $1.50 price target on the biopharmaceutical company’s stock. Acer Therapeutics Trading Down 10.9 % Acer Therapeutics stock opened at $1.14 on Friday. The […]
Shares of Acer Therapeutics Inc. (NASDAQ:ACER – Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.58 and traded as low as $0.92. Acer Therapeutics shares last traded at $0.94, with a volume of 69,983 shares changing hands. Analyst Ratings Changes Separately, HC […]
Acer Therapeutics Inc. (NASDAQ:ACER – Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.58 and traded as low as $0.92. Acer Therapeutics shares last traded at $0.94, with a volume of 69,983 shares. Wall Street Analyst Weigh In […]
SVB Wealth LLC purchased a new position in Acer Therapeutics Inc. (NASDAQ:ACER – Get Rating) in the fourth quarter, HoldingsChannel reports. The firm purchased 11,500 shares of the biopharmaceutical company’s stock, valued at approximately $29,000. Separately, Renaissance Technologies LLC lifted its position in Acer Therapeutics by 216.8% in the second quarter. Renaissance Technologies LLC now […]
Acer Therapeutics Inc. (NASDAQ:ACER – Get Rating) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 338,200 shares, a growth of 14.4% from the February 28th total of 295,600 shares. Based on an average trading volume of 556,500 shares, the short-interest ratio is presently 0.6 days. […]